Literature DB >> 17708599

Noninvasive diagnosis of hepatic fibrosis in chronic hepatitis C.

Rudolf-E Stauber1, Carolin Lackner.   

Abstract

Assessment of hepatic fibrosis is important for determining prognosis, guiding management decisions, and monitoring disease. Histological evaluation of liver biopsy specimens is currently considered the reference test for staging hepatic fibrosis. Since liver biopsy carries a small but significant risk, noninvasive tests to assess hepatic fibrosis are desirable. This editorial gives an overview on noninvasive methods currently available to determine hepatic fibrosis and their diagnostic accuracy for predicting significant fibrosis and cirrhosis in chronic hepatitis C. Based on available data, the performance of simple tests derived from routine laboratory parameters appears to be similar to that of more complex and expensive fibrosis panels. Transient elastography seems more accurate than blood tests for diagnosing cirrhosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17708599      PMCID: PMC4250852          DOI: 10.3748/wjg.v13.i32.4287

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  68 in total

1.  Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group.

Authors:  J G McHutchison; L M Blatt; M de Medina; J R Craig; A Conrad; E R Schiff; M J Tong
Journal:  J Gastroenterol Hepatol       Date:  2000-08       Impact factor: 4.029

2.  Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC.

Authors:  Christophe Corpechot; Ahmed El Naggar; Armelle Poujol-Robert; Marianne Ziol; Dominique Wendum; Olivier Chazouillères; Victor de Lédinghen; Daniel Dhumeaux; Patrick Marcellin; Michel Beaugrand; Raoul Poupon
Journal:  Hepatology       Date:  2006-05       Impact factor: 17.425

3.  Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis.

Authors:  Francesco Vizzutti; Umberto Arena; Roberto G Romanelli; Luigi Rega; Marco Foschi; Stefano Colagrande; Antonio Petrarca; Stefania Moscarella; Giacomo Belli; Anna Linda Zignego; Fabio Marra; Giacomo Laffi; Massimo Pinzani
Journal:  Hepatology       Date:  2007-05       Impact factor: 17.425

4.  Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging.

Authors:  Diego A Aguirre; Cynthia A Behling; Elliot Alpert; Tarek I Hassanein; Claude B Sirlin
Journal:  Radiology       Date:  2006-05       Impact factor: 11.105

5.  Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation.

Authors:  Jose A Carrión; Miquel Navasa; Jaume Bosch; Miquel Bruguera; Rosa Gilabert; Xavier Forns
Journal:  Liver Transpl       Date:  2006-12       Impact factor: 5.799

6.  Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

Authors:  Laurent Castéra; Julien Vergniol; Juliette Foucher; Brigitte Le Bail; Elise Chanteloup; Maud Haaser; Monique Darriet; Patrice Couzigou; Victor De Lédinghen
Journal:  Gastroenterology       Date:  2005-02       Impact factor: 22.682

7.  The long-term pathological evolution of chronic hepatitis C.

Authors:  M Yano; H Kumada; M Kage; K Ikeda; K Shimamatsu; O Inoue; E Hashimoto; J H Lefkowitch; J Ludwig; K Okuda
Journal:  Hepatology       Date:  1996-06       Impact factor: 17.425

8.  Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study.

Authors:  J Foucher; E Chanteloup; J Vergniol; L Castéra; B Le Bail; X Adhoute; J Bertet; P Couzigou; V de Lédinghen
Journal:  Gut       Date:  2005-07-14       Impact factor: 23.059

9.  Noninvasive estimation of liver fibrosis and response to interferon therapy by a serum fibrogenesis marker, YKL-40, in patients with HCV-associated liver disease.

Authors:  Yukiko Saitou; Katsuya Shiraki; Yutaka Yamanaka; Yumi Yamaguchi; Tomoyuki Kawakita; Norihiko Yamamoto; Kazushi Sugimoto; Kazumoto Murata; Takeshi Nakano
Journal:  World J Gastroenterol       Date:  2005-01-28       Impact factor: 5.742

10.  Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin.

Authors:  Thierry Poynard; John McHutchison; Michael Manns; Rob P Myers; Janice Albrecht
Journal:  Hepatology       Date:  2003-08       Impact factor: 17.425

View more
  8 in total

1.  Shear wave velocity is a useful marker for managing nonalcoholic steatohepatitis.

Authors:  Akihiko Osaki; Tomoyuki Kubota; Takeshi Suda; Masato Igarashi; Keisuke Nagasaki; Atsunori Tsuchiya; Masahiko Yano; Yasushi Tamura; Masaaki Takamura; Hirokazu Kawai; Satoshi Yamagiwa; Toru Kikuchi; Minoru Nomoto; Yutaka Aoyagi
Journal:  World J Gastroenterol       Date:  2010-06-21       Impact factor: 5.742

Review 2.  Clinical application of liver stiffness measurement using transient elastography in chronic liver disease from longitudinal perspectives.

Authors:  Beom Kyung Kim; James Fung; Man-Fung Yuen; Seung Up Kim
Journal:  World J Gastroenterol       Date:  2013-03-28       Impact factor: 5.742

3.  Evaluation of the aspartate aminotransferase/platelet ratio index and enhanced liver fibrosis tests to detect significant fibrosis due to chronic hepatitis C.

Authors:  John R Petersen; Heather L Stevenson; Krishna S Kasturi; Ashutosh Naniwadekar; Julie Parkes; Richard Cross; William M Rosenberg; Shu-Yuan Xiao; Ned Snyder
Journal:  J Clin Gastroenterol       Date:  2014-04       Impact factor: 3.062

4.  Microbial translocation and liver disease progression in women coinfected with HIV and hepatitis C virus.

Authors:  Audrey L French; Charlesnika T Evans; Denis M Agniel; Mardge H Cohen; Marion Peters; Alan L Landay; Seema N Desai
Journal:  J Infect Dis       Date:  2013-05-17       Impact factor: 5.226

5.  Macrophage Activation and the Tumor Necrosis Factor Cascade in Hepatitis C Disease Progression Among HIV-Infected Women Participating in the Women's Interagency HIV Study.

Authors:  Audrey L French; Jonathan W Martin; Charlesnika T Evans; Marion Peters; Seble G Kessaye; Marek Nowicki; Mark Kuniholm; Elizabeth Golub; Michael Augenbraun; Seema N Desai
Journal:  J Acquir Immune Defic Syndr       Date:  2017-12-01       Impact factor: 3.731

6.  Noninvasive diagnosis of liver fibrosis and cirrhosis in chronic hepatitis C patients.

Authors:  Abdelfattah M Attallah; Mohamed El-Far; Mohamed M Omran; Khaled Farid; Mohamed S Albannan; Ibrahim El-Dosoky
Journal:  J Clin Lab Anal       Date:  2013-03-04       Impact factor: 2.352

7.  Elastography for hepatic fibrosis severity in chronic hepatitis B or C.

Authors:  Maria-Vasiliki Papageorgiou; George V Papatheodoridis; Spilios Manolakopoulos; Emmanuel Tsochatzis; Hariklia Kranidioti; Georgia Kafiri; Athanasios I Archimandritis
Journal:  Case Rep Gastroenterol       Date:  2011-01-29

Review 8.  Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.

Authors:  Chanbin Lee; Jieun Kim; Youngmi Jung
Journal:  Cells       Date:  2019-10-15       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.